AAP
42
3
ZBH
47
-12
WU
41
3
PFG
67
2
ADBE
44
3
DE
48
5
V
42
-2
PVH
64
5
CVS
39
-4
CSX
54
4
SLB
44
5
NWSA
64
4
HUM
36
7
ETR
57
5
HBAN
79
5
CME
49
-3
HRL
47
2
CHD
34
2
ROP
50
5
BXP
46
-3
AAP
42
3
ZBH
47
-12
WU
41
3
PFG
67
2
ADBE
44
3
DE
48
5
V
42
-2
PVH
64
5
CVS
39
-4
CSX
54
4
SLB
44
5
NWSA
64
4
HUM
36
7
ETR
57
5
HBAN
79
5
CME
49
-3
HRL
47
2
CHD
34
2
ROP
50
5
BXP
46
-3
Financhill
Back

Fulgent Genetics, Inc. 10K Form

Buy
56

FLGT
Fulgent Genetics, Inc.

Last Price:
$28.30
Seasonality Move:
15.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FLGT News And Ratings

See the #1 stock for the next 7 days that we like better than FLGT

FLGT Financial Statistics

Sales & Book Value

Annual Sales: $283.5M
Cash Flow: $5.1M
Price / Cash Flow: 57.7
Annual Sales: $36.49
Price / Book: 0.78

Profitability

EPS (TTM): -1.40160
Net Income (TTM): $-44.2M
Gross Margin: $99.3M
Return on Equity: -3.93%
Return on Assets: -3.61%

Fulgent Genetics, Inc. Earnings Forecast

Key Fulgent Genetics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 11 years for FLGT is 35.01%.
  • The Selling, General & Administrative Expenses for FLGT have been equal to 43.87% of Gross Profit Margin.
  • The Research & Development expenses have been 17.22% of Revenue.
  • The Net Earning history of FLGT is -15.46% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Fulgent Genetics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: FLGT
CUSIP: 359664
Website: fulgentgenetics.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 7.01
Quick Ratio: 6.47

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FLGT Technical Analysis vs Fundamental Analysis

Buy
56
Fulgent Genetics, Inc. (FLGT) is a Buy

Is Fulgent Genetics, Inc. a Buy or a Sell?